PBA
GRCL

Paradigm Biocapital Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Paradigm Biocapital Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-783,445
Closed -$4.31M – 31
2022
Q2 		$4.31M Hold
783,445
– – 0.86% 21
2022
Q1 		$1.83M Buy
783,445
+238,057
+44% +$555K 0.48% 25
2021
Q4 		$3.29M Buy
+545,388
New +$3.29M 0.94% 24